Tumorigenic and Mitogenic Capacities Are Reduced in Transfected Fibroblasts Expressing Mutant Insulin-Like Growth Factor (IGF)-I Receptors. The Role of Tyrosine Residues 1250, 1251, and 1316 in the Carboxy-Terminus of the IGF-I Receptor

Vicky A. Blakesley, Thea Kalebic, Lee J. Helman, Bethel Stannard, Teresa N. Faria, Charles T. Roberts, Derek Leroith

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Tumorigenic and Mitogenic Capacities Are Reduced in Transfected Fibroblasts Expressing Mutant Insulin-Like Growth Factor (IGF)-I Receptors. The Role of Tyrosine Residues 1250, 1251, and 1316 in the Carboxy-Terminus of the IGF-I Receptor'. Together they form a unique fingerprint.

Sort by
Weight
Alphabetically

Tumorigenic and Mitogenic Capacities Are Reduced in Transfected Fibroblasts Expressing Mutant Insulin-Like Growth Factor (IGF)-I Receptors. The Role of Tyrosine Residues 1250, 1251, and 1316 in the Carboxy-Terminus of the IGF-I Receptor

Fingerprint

Medicine & Life Sciences